Dr. TANIA RAY (BHADRA)

DR. ANKITA MITRA, DR. ANAMIKA PAUL, Dr. GHOSH RUDRA PRASAD

Abstract

Objectives

To determine the safety & efficacy of AM-UC graft in Glaucoma shunt surgery for reducing glaucoma shunt tube exposure.

Method:

Prospective interventional study.50 eyes of 50 patients with refractory glaucoma underwent glaucoma shunt surgery.Tubes were inserted into anterior chamber & pars plana. Tubes were covered with AM-UC patch grafts. AS-OCT were used to asses the patch graft stability & host tissue integration.

Result:

Mean age 50 +/- 5 years & follow-up 24+/- 3 month.Tube exposure occurred in 1 eye (2%) at 3 months. Sequential AS-OCT showed excellent host tissue integration. Early graft thinning occurred in 6 eyes (12%) & late thinning occurred in 2 eyes (4%). No evidence of graft rejection or infection .

Conclusion

AM-UC grafts are well tolerated & Its high-tensile strength, low immunogenicity & excellent host- tissue integration offer good tectonic support in glaucoma shunt surgery & beneficial when limited cornea donor & eye banking services in COVID 19.

Full Text